AROMASIN is indicated for adjuvant therapy of postmenopausal Ladies with estrogen-receptor constructive early breast cancer that have been given two to 3 yrs of tamoxifen and so are switched to AROMASIN for completion of a complete of 5 consecutive years of adjuvant hormonal therapy [see Scientific Reports (14.1)]. Exemestane has https://yurii369qpc0.webbuzzfeed.com/profile